Literature DB >> 7905146

QT dispersion and sudden unexpected death in chronic heart failure.

C S Barr1, A Naas, M Freeman, C C Lang, A D Struthers.   

Abstract

Death in chronic heart failure (CHF) can be from progression of disease or sudden and unexpected. We have attempted to identify factors that predict sudden death in CHF. We followed up 44 patients with CHF for 12-50 (mean 36) months. 4 patients died of non-cardiovascular causes and were excluded from analysis. There were 7 sudden deaths (symptoms for less than 1 h in a previously stable patient) and 12 from progressive CHF. Patients who died of progressive CHF had lower left-ventricular ejection fractions and higher concentrations of atrial natriuretic factor than the 21 survivors, but there were no differences in these variables between survivors and those who died suddenly. However, the sudden death group had significantly (p < 0.05) greater inter-lead variability in the QT interval on the electrocardiogram (QT dispersion; 98.6 [95% CI 79.1-118] ms1/2) than survivors (53.1 [41.9-64.3] ms1/2) or the group who died from progressive CHF (66.7 [51.8-81.6] ms1/2). QT dispersion is a marker of myocardial electrical instability. The association of increased QT dispersion with sudden death suggests that patients at high risk of such death could be identified by means of this simple, reproducible test. This group might benefit from more intensive treatment.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7905146     DOI: 10.1016/s0140-6736(94)91164-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  137 in total

1.  Automatic detection of the electrocardiogram T-wave end.

Authors:  I K Daskalov; I I Christov
Journal:  Med Biol Eng Comput       Date:  1999-05       Impact factor: 2.602

2.  Correction for heart rate is not necessary for QT dispersion in individuals without structural heart disease and patients with ventricular tachycardia.

Authors:  Vassilios P Vassilikos; Labros A Karagounis; Apostolos Psichogios; Themistoclis Maounis; John Iakovou; Antonis S Manolis; Dennis V Cokkinos
Journal:  Ann Noninvasive Electrocardiol       Date:  2002-01       Impact factor: 1.468

Review 3.  Why does spironolactone improve mortality over and above an ACE inhibitor in chronic heart failure?

Authors:  A D Struthers
Journal:  Br J Clin Pharmacol       Date:  1999-05       Impact factor: 4.335

4.  Evaluation of serial QT dispersion in patients with first non-Q-wave myocardial infarction: relation to the severity of underlying coronary artery disease.

Authors:  T G Lyras; V A Papapanagiotou; M G Foukarakis; F K Panou; N D Skampas; J A Lakoumentas; C V Priftis; A A Zacharoulis
Journal:  Clin Cardiol       Date:  2003-04       Impact factor: 2.882

5.  Measuring QT dispersion: man versus machine.

Authors:  A Murray; N B McLaughlin; R W Campbell
Journal:  Heart       Date:  1997-06       Impact factor: 5.994

6.  Seasonal variability of QT dispersion in healthy young males.

Authors:  Sedat Kose; Kudret Aytemir; Ilknur Can; Atilla Iyisoy; Hurkan Kursaklioglu; Basri Amasyali; Ayhan Kilic; Ersoy Isik; Ali Oto; Ertan Demirtas
Journal:  Ann Noninvasive Electrocardiol       Date:  2003-01       Impact factor: 1.468

7.  Aging modulates dispersion of ventricular repolarization in the very old of the geriatric population.

Authors:  Jen-Hung Huang; Ying-Qin Lin; Nan-Hung Pan; Yi-Jen Chen
Journal:  Heart Vessels       Date:  2010-10-09       Impact factor: 2.037

8.  QT interval dispersion analysis in patients undergoing left partial ventriculectomy (Batista operation).

Authors:  Carlos Alberto Pastore; Sandra Regina Arcêncio; Nancy M M O Tobias; Elisabeth Kaiser; Martino Martinelli Filho; Luis Felipe P Moreira; Noedir A Stolf; Edimar Bocchi; José Antonio Franchini Ramires
Journal:  Ann Noninvasive Electrocardiol       Date:  2004-10       Impact factor: 1.468

Review 9.  [Standard-ECG].

Authors:  Bernd-Dieter Gonska
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2008-09

Review 10.  Genetics of acquired long QT syndrome.

Authors:  Dan M Roden; Prakash C Viswanathan
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.